Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses.
from NDTV Profit-Latest https://ift.tt/qsG20bt
from NDTV Profit-Latest https://ift.tt/qsG20bt
Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables
![Dr Reddy's To Earmark Rs 1,500 Crore Capex For Biosimilars, Injectables]()
Reviewed by placements page
on
November 06, 2022
Rating:
No comments: